Recursion Pharmaceuticals RXRX is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for ...

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to ...

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP) NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bionic Sight, Inc., a company ...

Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...

USAID's stop-work order threatens to undo decades of progress in medical research ethics and cause harm to clinical trial ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. Click here to read more about IQV stock and why it is rated ...

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

Finding a clinical trial that is a good fit can be challenging. Here's how to get the most out of your clinical trial search.